Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
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
xjNthZfM0Hwn6a3R
Écouter
